Biopharmaceutical Contract Manufacturing Market Size to Exceed USD 18.7 Bn in 2029
Global biopharmaceutical contract manufacturing market is estimated to be worth US$ 9.3 billion in 2022 and is expected to grow at a CAGR of 10.5% to cross US$ 18.7 billion by 2029. Reduced overall time to market investment in new drugs, access to expensive technologies, and greater flexibility are some advantages offered by biopharmaceutical manufacturing companies. On the back...
0 Σχόλια 0 Μοιράστηκε 3χλμ. Views 0 Προεπισκόπηση